Bristol Myers Squibb Co stock is traded at $59.19, with a volume of 5,027,033. It is up +1.46% in the last 24 hours and down -4.04% over the past month. Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Previous Close:
$58.34
Open:
$59.16
24h Volume:
5,027,033
Relative Volume:
0.50
Market Cap:
$120.99B
Revenue:
$48.48B
Net Income/Loss:
$7.27B
P/E Ratio:
16.61
EPS:
$3.56
Net Cash Flow:
$11.91B
1W Performance:
-6.68%
1M Performance:
-4.04%
6M Performance:
+1.11%
1Y Performance:
+28.84%
1-Day Range:
$58.73$59.81
1-Week Range:
$57.88$64.94
52-Week Range:
$45.27$68.64
Bristol Myers Squibb Co Stock (BMY) Company Profile
Name
Bristol Myers Squibb CoSector
HealthcareIndustry
Drug Manufacturers - GeneralPhone
(609) 252-4621Address
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NY, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS